drugset / Trial / NCT06060080

Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma

NCT06060080

Unknown 7 enrolled Yao Liu
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the effectiveness and safety of PEG-rhG-CSF injection for the reconstruction of neutrophil cells after autologous hematopoietic stem cell transplantation in lymphoma/multiple myeloma patients.

Timeline

Start
2022-04-22
Primary completion
2023-12-31
Completion
2024-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Pegfilgrastim Protein / enzyme biologic 6 mg

Indications